Where next for patient centricity in pharma?As patient centricity seems to be hitting a slump, Paul Tunnah lays out the key factors companies need Share XWhere next for patient centricity in pharma?https://pharmaphorum.com/views-analysis-patients/where-next-for-patient-centricity-in-pharma/
A blueprint for building a patient-centric pharma companyWhile the industry appears united in its commitment to patient centricity, the practicalities of embedding the ethos into Share XA blueprint for building a patient-centric pharma companyhttps://pharmaphorum.com/views-analysis-patients/whitepaper-provides-a-blueprint-to-building-a-patient-centricity-company/
Towards patient centricity: GSKEmbedding the patient voice into the DNA of a pharmaceutical company isn’t easy – but it is essential. Share XTowards patient centricity: GSKhttps://pharmaphorum.com/patients/towards-patient-centricity-gsk/
Removing logistical barriers to improve clinical trial retentionWe all know how long and arduous the clinical trial road is for sites and sponsors – but Share XRemoving logistical barriers to improve clinical trial retentionhttps://pharmaphorum.com/views-analysis-patients/removing-logistical-barriers-to-improve-clinical-trial-retention/
Towards patient centricity: PfizerIn a new series Amanda Barrell looks at how different companies are turning patient centricity into a reality. Share XTowards patient centricity: Pfizerhttps://pharmaphorum.com/views-and-analysis/towards-patient-centricity-pfizer/
Why pharma isn’t collaborating with patient organisations as much as it shouldPatient centricity has rapidly gone from a fringe idea to a fundamental principle across the industry, but are Share XWhy pharma isn’t collaborating with patient organisations as much as it shouldhttps://pharmaphorum.com/views-and-analysis/why-pharma-isnt-collaborating-with-patient-organisations-as-much-as-it-should/
The rise and rise of patient centricityGeorge Underwood looks at the rapid growth of patient centricity over the last few years and considers what Share XThe rise and rise of patient centricityhttps://pharmaphorum.com/views-and-analysis/the-rise-and-rise-of-patient-centricity/
Exclusive Interview with AstraZeneca’s Former VP, Medical Evidence & Observational ResearchAhead of the 7th Annual IMPACCT: Real World Evidence, Sandy Leonard, former VP, Medical Evidence & Observational Research Share XExclusive Interview with AstraZeneca’s Former VP, Medical Evidence & Observational Researchhttps://pharmaphorum.com/partner-content/exclusive-interview-with-astrazenecas-former-vp-medical-evidence-observational-research/
Patients in the driving seatMany pharma companies talk about the importance of ‘patient centric’ clinical trials and involving patients in trial design – Share XPatients in the driving seathttps://pharmaphorum.com/r-d/patients-in-the-driving-seat/
